CME Group(US:CME) ZACKS·2025-10-22 14:31Core Insights - CME Group reported $1.54 billion in revenue for Q3 2025, a 3% year-over-year decline, with EPS remaining flat at $2.68 compared to the previous year [1] - The revenue exceeded the Zacks Consensus Estimate of $1.53 billion by 0.81%, while the EPS surpassed the consensus estimate of $2.63 by 1.9% [1] Financial Performance Metrics - Average daily volume was 25.32 million, slightly below the estimated 26.2 million [4] - Average rates per contract varied across categories, with interest rates at $0.49 (vs. $0.48 estimate), equity indexes at $0.65 (matching estimate), foreign exchange at $0.84 (vs. $0.79 estimate), energy at $1.21 (vs. $1.19 estimate), and agricultural commodities at $1.42 (vs. $1.40 estimate) [4] - Average daily volume for metals was 825 thousand, below the estimated 843.54 thousand [4] - Revenues from clearing and transaction fees were $1.23 billion, below the $1.25 billion estimate, reflecting a year-over-year decline of 5.3% [4] - Revenues from other sources were $107.2 million, slightly below the $110.22 million estimate, with a year-over-year decline of 1.7% [4] - Market data and information services revenues were $202.5 million, exceeding the $195.57 million estimate, with a year-over-year increase of 13.6% [4] Stock Performance - CME shares returned +2.5% over the past month, outperforming the Zacks S&P 500 composite's +1.1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]